Eversheds Ireland plays key role in the takeover of Paladin Labs by Endo Health
Eversheds Ireland has played a key role in the takeover by Endo Health Solutions of Paladin Labs Europe for approximately £1.1bn.
In this transaction, the acquiring entity will be an Irish holding company. The deal is the first Irish inversion with no primary Irish target.
An inversion is a legal transaction whereby one corporation becomes a subsidiary of another headquartered in a foreign jurisdiction and as a result the original corporation becomes subject to the tax laws of the foreign jurisdiction instead.
News from Eversheds
News from The Lawyer
Briefings from Eversheds
The Pensions Regulator has published a new code of practice on funding defined benefits ’to minimise any adverse impact on the sustainable growth of an employer’.
On 8 April 2014, the European Court of Justice in the Digital Rights Ireland case declared the Data Retention Directive 2006/24/EC invalid
Analysis from The Lawyer
A new breed of lawyer is smoothing the path for companies entering emerging or unstable jurisdictions
‘Exotic’ investors and opportunities for legal work beyond M&A feature in The Lawyer’s high-level roundtable debate on south-east Europe